严查欺诈骗保！国家医保局公布八起典型案例

Core Viewpoint - The National Medical Insurance Administration (NMIA) has launched a nationwide campaign to combat fraud and illegal activities in the pharmaceutical sector, utilizing drug traceability codes as a key tool, and has announced eight typical cases of fraud [1][2]. Group 1: Fraud Cases - Eight typical cases of fraud have been identified, including: - A pharmacy in Lanzhou, Gansu Province, involved in card swiping and reselling medical insurance drugs [1]. - Nine pharmacies in Wuhan, Hubei Province, participating in the resale of medical insurance drugs [1]. - A pharmacy in Changsha, Hunan Province, that forged prescriptions to defraud medical insurance funds [1]. - A pharmacy in Fuzhou, Jiangxi Province, involved in swapping and reselling medical insurance drugs [1]. - A clinic in Hefei, Anhui Province, that illegally purchased and resold drugs from online retail platforms [1]. - A chain company in Yangquan, Shanxi Province, that induced false drug purchases [1]. - A doctor in Xi'an, Shaanxi Province, who prescribed excessive medications and issued illegal prescriptions [1]. - An insured individual in Shanghai who purchased excessive medications [1]. Group 2: Role of Drug Traceability Codes - Drug traceability codes serve as a unique "electronic ID" for each box of medication, essential for ensuring compliance in procurement and settlement processes [2]. - All medical insurance designated institutions are required to procure drugs with traceability codes and settle payments via scanning [2]. - The NMIA encourages insured individuals to use the national medical insurance app to scan the traceability codes on drug packages to protect their legal rights against suspected fraudulent activities [2].